Theranica clinical trials
The registry lists 27 studies whose lead sponsor is Theranica. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 27studies on the registry
- 3open to participants now
- 2reach primary completion within a year
Get an email when these change. Save the Theranica studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
2 of Theranica’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- DDec
- JJan ’27’27
- FFeb
- MMar
- AApr
- MMay
- 1JJun
- JJul
- 1AAug
- SSep
- OOct
- NNov
All 2
Add all 2 to your calendar (.ics) → With an account.
All 27 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 523
- 24
- 25
- 526
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Theranica.
- Theranica27 studiesSame company
Something wrong?
Focus areas
Conditions Theranica leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 27 of 27.
- An Open Label Study Assessing REN Treatment in Headache Management in Temporomandibular DisordersRecruitingNCT07639944Not applicable
- The Effect of Remote Electrical Neuromodulation (REN) on Conditioned Pain Modulation (CPM) in Migraine and FibromyalgiaRecruitingNCT07841509Not applicable
- Treatment of Fibromyalgia With the FibroNova Neuromodulation DeviceRecruitingNCT06271746Not applicable
- Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence StudyCompletedNCT07487701Not applicable
- Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine TreatmentCompletedNCT07336420Phase 4
- Nerivio Efficacy Under High-Frequency UseActive, not recruitingNCT07336056Phase 4
- Machine Learning Assessment of Next-Day Migraine LikelihoodCompletedNCT07227194
- Real-world Data Analysis of REN Treatment in Adolescence With MigraineCompletedNCT05443659
- Safety of Nerivio in Pregnant Women With MigraineCompletedNCT05464069
- Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)CompletedNCT06138756
- Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) TreatmentCompletedNCT06023953
- Nerivio Efficacy by Time of Treatment OnsetCompletedNCT06976723Phase 4
- Migraine Treatment With Nerivio Migra Neurostimulation DeviceTerminatedNCT03076515Not applicable
- Nerivio Long-term Usage in Patients With MigraineCompletedNCT06738056
- Observational Study to Assess Migraine Prediction ToolSuspendedNCT05523310
- Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in AdolescenceCompletedNCT05769322
- Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)CompletedNCT05760638
- A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.CompletedNCT05940870
- Real-world Data Analysis of REN Treatment in Migraine PatientsCompletedNCT04992897
- A Survey Study to Assess the Accessibility of the Nerivio Device At SchoolCompletedNCT06180577
- Assessment of Safety and Efficacy of Nerivio for the Migraine PreventionCompletedNCT04828707Not applicable
- Evaluation of a Novel Device for Treatment of Migraine HeadacheCompletedNCT03361423Not applicable
- Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in AdolescentsTerminatedNCT04089761Not applicable
- Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic MigraineCompletedNCT04161807Not applicable
- Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic MigraineCompletedNCT04194008Not applicable
- Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual MigraineCompletedNCT04600388
- Relief of Migraine Pain Through Electro StimulationCompletedNCT02453399Not applicable